MGB
RVMD icon

Mass General Brigham’s Revolution Medicines RVMD Stock Holding History

Mass General Brigham’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64.4M Hold
344,091
– – 17.85% 3
2026
Q1 		$33.5M Hold
344,091
– – 7.14% 3
2025
Q4 		$27.4M Buy
+344,091
New +$22.6M 3.38% 3
2024
Q3 		$15.3M Hold
338,191
– – 35.15% 2
2024
Q2 		$13.1M Hold
338,191
– – 63.9% 1
2024
Q1 		$10.9M Buy
+338,191
New +$10M 19.08% 2
2023
Q2 		– Sell
-338,191
Closed -$7.33M – 9
2023
Q1 		$7.33M Buy
338,191
+316,767
+1,479% +$7.8M 5.71% 4
2022
Q4 		$510K Buy
+21,424
New +$456K 0.36% 5

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Mass General Brigham's RVMD Position: Q2 2026 in Review

Mass General Brigham held its Revolution Medicines (RVMD) position steady in Q2 2026 at 344,091 shares worth $64.4M. The position accounts for 17.85% of the portfolio, ranked #3.

Mass General Brigham first reported a position in RVMD in Q4 2022 and has held it in 8 quarters since. 399 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Mass General Brigham held 344,091 shares of Revolution Medicines worth $64.4M as of Q2 2026.
  • Mass General Brigham left its Revolution Medicines share count unchanged in Q2 2026.
  • Revolution Medicines made up 17.85% of Mass General Brigham's portfolio in Q2 2026, its #3 holding.
  • Mass General Brigham first reported a position in Revolution Medicines in Q4 2022 and has held it in 8 quarters since.
  • 399 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Mass General Brigham's 13F filing for Q2 2026, filed 7 Aug 2026.